文献速递糖尿病

日本妊娠期糖尿病类型与围产期不良结局:基于大规模数据库的队列研究

Diabetes Type and Perinatal Adverse Outcomes Among Women in Pregnancy and Neonates in Japan: A Cohort Study Using a Large‐Scale Database
RSS 订阅 · Diabetes, Obesity and Metabolism · 2026-11-10

基于JMDC理赔数据库的回顾性队列研究,纳入2015至2024年205594名母亲的244402名新生儿,比较血糖正常、妊娠期糖尿病、孕前糖尿病和妊娠期显性糖尿病的母婴结局。妊娠期显性糖尿病较孕前糖尿病的严重新生儿并发症风险更高(aOR 1.31,95%CI 1.07–1.59),子痫前期/子痫风险无统计学显著差异。

要点

  • 妊娠期显性糖尿病较孕前糖尿病的严重新生儿并发症风险更高(aOR 1.31,95%CI 1.07–1.59)。
  • 妊娠期显性糖尿病与孕前糖尿病的子痫前期/子痫风险无统计学显著差异(aOR 0.96,95%CI 0.67–1.40)。
  • 妊娠期糖尿病、孕前糖尿病和妊娠期显性糖尿病的母婴风险均高于血糖正常,且风险随高血糖状态类型变化。

核心结论

  • 母婴风险随高血糖状态类型而变化;妊娠期显性糖尿病较孕前糖尿病的严重新生儿并发症风险更高,子痫前期/子痫风险无统计学显著差异;作者认为需用围绕妊娠的纵向数据进一步验证。

研究设计与样本

  • 使用JMDC理赔数据库开展的回顾性队列研究,纳入2015至2024年的母婴配对,共244402名新生儿来自205594名母亲;依据诊断、处方、操作和时间将母亲血糖状态分为血糖正常、妊娠期糖尿病、孕前糖尿病和妊娠期显性糖尿病。

主要发现

  • 妊娠期糖尿病、孕前糖尿病和妊娠期显性糖尿病分别为20116例(8.2%)、3287例(1.3%)和901例(0.4%)。
  • 与血糖正常相比,妊娠期糖尿病、孕前糖尿病和妊娠期显性糖尿病的子痫前期/子痫aOR分别为1.34(95%CI 1.21–1.48)、1.96(95%CI 1.64–2.33)和1.89(95%CI 1.35–2.64)。
  • 与血糖正常相比,妊娠期糖尿病、孕前糖尿病和妊娠期显性糖尿病的严重新生儿并发症aOR分别为1.45(95%CI 1.38–1.52)、1.95(95%CI 1.77–2.15)和2.55(95%CI 2.14–3.03)。
  • 与孕前糖尿病直接比较,妊娠期显性糖尿病的严重新生儿并发症aOR为1.31(95%CI 1.07–1.59),子痫前期/子痫aOR为0.96(95%CI 0.67–1.40),未达统计学显著。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为需用围绕妊娠的纵向数据进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Aims To compare maternal and neonatal outcomes across gestational diabetes, preexisting diabetes, overt diabetes in pregnancy and normoglycaemia in Japan. Materials and Methods Using the JMDC claims database, we conducted a retrospective cohort study of mother–neonate pairs from 2015 to 2024. Maternal glycaemic status was classified as normoglycaemia, gestational diabetes, preexisting diabetes or overt diabetes in pregnancy using diagnoses, prescriptions, procedures and timing. Multivariable logistic regression estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for maternal pre-eclampsia/eclampsia and severe neonatal complications (neonatal death, foetal distress or neonatal intensive care unit admission). Results Among 244 402 neonates from 205 594 mothers, gestational diabetes, preexisting diabetes and overt diabetes were identified in 20 116 (8.2%), 3287 (1.3%) and 901 (0.4%), respectively. Compared with normoglycaemia, gestational diabetes, preexisting diabetes and overt diabetes were associated with higher risks of maternal pre-eclampsia/eclampsia, with aORs of 1.34 (95% CI: 1.21–1.48), 1.96 (1.64–2.33) and 1.89 (1.35–2.64), respectively. Corresponding aORs for severe neonatal complications were 1.45 (1.38–1.52), 1.95 (1.77–2.15) and 2.55 (2.14–3.03), respectively. Compared directly with preexisting diabetes, overt diabetes was associated with higher odds of severe neonatal complications (aOR: 1.31; 95% CI: 1.07–1.59), with no statistically significant difference detected in maternal pre-eclampsia/eclampsia (aOR: 0.96; 95% CI: 0.67–1.40). Conclusions Maternal and neonatal risks varied by hyperglycaemic status. Overt diabetes was associated with a higher risk of severe neonatal complications than preexisting diabetes, with no statistically significant difference detected in maternal pre-eclampsia/eclampsia. Further validation using longitudinal data around pregnancy is warranted.

来源:Diabetes, Obesity and Metabolism,查看原文。版权归原作者所有。

引用

  1. Diabetes, Obesity and Metabolism:Diabetes Type and Perinatal Adverse Outcomes Among Women in Pregnancy and Neonates in Japan: A Cohort Study Using a Large‐Scale Database

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。